房颤风险对心源性栓塞与非心源性栓塞卒中的鉴别价值
本研究在1431例急性缺血性卒中患者中横断面分析,系统判定卒中 subtype 并比较三种房颤风险评分(CHA2DS2-VASc、CHARGE-AF、EHR-AF)与心源性栓塞的关联及鉴别能力。结果显示房颤风险评分与心源性栓塞显著相关,鉴别能力中等,EHR-AF评分可能有助于识别心源性栓塞低概率个体。
要点
- 房颤风险评分与心源性栓塞卒中显著相关。
- EHR-AF评分鉴别能力中等,优于CHA2DS2-VASc。
- 房颤风险评分或有助于识别心源性栓塞低概率患者。
核心结论
- 房颤风险评分与心源性栓塞卒中相关且具有中等鉴别能力,可能最适用于识别心源性栓塞低概率个体。
研究设计与样本
- 多机构横断面分析,纳入1431例急性缺血性卒中患者,系统判定卒中 subtype 并比较三种房颤风险评分与心源性栓塞的关联及鉴别能力。
主要发现
- 1431例缺血性卒中患者(年龄65±15岁,40%女性)中323例(22.6%)为心源性栓塞。
- 房颤风险与心源性栓塞显著相关:CHA2DS2-VASc每增加1个标准差OR 1.69(95%CI 1.49-1.93);CHARGE-AF评分OR 2.22(95%CI 1.90-2.60);EHR-AF评分OR 2.55(95%CI 2.16-3.04)。
- 鉴别能力:CHARGE-AF评分C指数0.695(95%CI 0.663-0.726),EHR-AF评分C指数0.713(95%CI 0.681-0.744),均高于CHA2DS2-VASc的C指数0.651(95%CI 0.619-0.683)。
- EHR-AF评分在敏感性阈值0.90-0.99时,阴性似然比范围为0.31-0.10,提示有助于识别低概率心源性栓塞个体。
临床怎么用
- 在卒中急性期可考虑使用房颤风险评分(如EHR-AF)辅助识别心源性栓塞低概率患者,以帮助判断是否需要抗凝。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Classification of stroke as cardioembolic in etiology can be challenging, particularly since the predominant cause, atrial fibrillation (AF), may not be present at the time of stroke. Efficient tools that discriminate cardioembolic from noncardioembolic strokes may improve care as anticoagulation is frequently indicated after cardioembolism. We sought to assess and quantify the discriminative power of AF risk as a classifier for cardioembolism in a real-world population of patients with acute ischemic stroke. Methods- We performed a cross-sectional analysis of a multi-institutional sample of patients with acute ischemic stroke. We systematically adjudicated stroke subtype and examined associations between AF risk using CHA2DS2-VASc, Cohorts for Heart and Aging Research in Genomic Epidemiology-AF score, and the recently developed Electronic Health Record-Based AF score, and cardioembolic stroke using logistic regression. We compared the ability of AF risk to discriminate cardioembolism by calculating C statistics and sensitivity/specificity cutoffs for cardioembolic stroke. Results- Of 1431 individuals with ischemic stroke (age, 65±15; 40% women), 323 (22.6%) had cardioembolism. AF risk was significantly associated with cardioembolism (CHA2DS2-VASc: odds ratio [OR] per SD, 1.69 [95% CI, 1.49-1.93]; Cohorts for Heart and Aging Research in Genomic Epidemiology-AF score: OR, 2.22 [95% CI, 1.90-2.60]; electronic Health Record-Based AF: OR, 2.55 [95% CI, 2.16-3.04]). Discrimination was greater for Cohorts for Heart and Aging Research in Genomic Epidemiology-AF score (C index, 0.695 [95% CI, 0.663-0.726]) and Electronic Health Record-Based AF score (0.713 [95% CI, 0.681-0.744]) versus CHA2DS2-VASc (C index, 0.651 [95% CI, 0.619-0.683]). Examination of AF scores across a range of thresholds indicated that AF risk may facilitate identification of individuals at low likelihood of cardioembolism (eg, negative likelihood ratios for Electronic Health Record-Based AF score ranged 0.31-0.10 at sensitivity thresholds 0.90-0.99). Conclusions- AF risk scores associate with cardioembolic stroke and exhibit moderate discrimination. Utilization of AF risk scores at the time of stroke may be most useful for identifying individuals at low probability of cardioembolism. Future analyses are warranted to assess whether stroke subtype classification can be enhanced to improve outcomes in undifferentiated stroke.
引用
- Khurshid S, Trinquart L, Weng LC, et al. Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke. Stroke. 2020. PMID: 32252601. doi:10.1161/STROKEAHA.120.028837
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。